The Neuropeptides VIP / PACAP and T Cells: Inhibitors or Activators?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|12|997-1004

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.12, 2003-05, pp. : 997-1004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VIP and PACAP in pain and inflammation

By Said S.I.S.I.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 2, 2000-02 ,pp. : 57-57

Elsevier

Access to resources Recommend Favorite

VIP and PACAP: very important in pain?

By Dickinson T.   Fleetwood-Walker S.M.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 324-329

Elsevier

Access to resources Recommend Favorite

Differences in Biological Activity Between PACAP27 and VIP in PC12 Cells Depend on Their N-Terminal Structures

By Onoue Satomi   Nagano Yumiko   Endo Kosuke   Yajima Takehiko   Kashimoto Kazuhisa  

Pharmacology Communications, Vol. 12, Iss. 4, 2002-10 ,pp. : 205-213

Taylor & Francis Ltd

Access to resources Recommend Favorite

Interaction of lipophilic VIP derivatives with recombinant VIP 1 /PACAP and VIP 2 /PACAP receptors

By Gourlet P.   Rathe J.   De Neef P.   Cnudde J.   Vandermeers-Piret M.-C.   Waelbroeck M.   Robberecht P.  

European Journal of Pharmacology, Vol. 354, Iss. 1, 1998-07 ,pp. : 105-111

Elsevier

Access to resources Recommend Favorite

Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 10, 2011-04 ,pp. : 1025-1035

Bentham Science Publishers

Access to resources Recommend Favorite